Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Caplin Point Laboratories Limited ( (IN:CAPLIPOINT) ) is now available.
Caplin Point Laboratories Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The company also appointed Mr. Ashok Partheeban and Mr. Vivek Partheeban as Additional Directors and Vice-Chairmen, with Mr. Vivek Partheeban relinquishing his position as Chief Operating Officer. Additionally, Dr. K C John was appointed as a Non-Executive Independent Director for a five-year term.
More about Caplin Point Laboratories Limited
Average Trading Volume: 6,399
Technical Sentiment Signal: Buy
Current Market Cap: 152B INR
Learn more about CAPLIPOINT stock on TipRanks’ Stock Analysis page.